Early genetic changes involved in low-grade astrocytic tumor development
Dolores Arjona1, Juan Antonio Rey, Shirley M Taylor
1Department of Microbiology, Virginia Commonwealth University, Richmond, VA 23298, USA, and Laboratorio de Oncogenética Molecular, Unidad de Investigación, Hospital Universitario La Paz, Madrid, Spain. mdarjona@vcu.edu
Current Molecular Medicine
|October 7, 2006
Summary
This review explores early genetic changes in low-grade astrocytomas, the most common glial tumors. Understanding these initial alterations may enable earlier detection and treatment of malignant astrocytoma progression.
Area of Science:
- Neuro-oncology
- Cancer genetics
- Molecular pathology
Background:
- Astrocytomas are the most frequent glial tumors.
- Glioblastoma multiforme (GBM) is the highest grade astrocytoma.
- GBM can develop from lower-grade astrocytomas or arise de novo.
Purpose of the Study:
- To review the earliest genetic alterations in the development of low-grade astrocytic tumors.
- To identify potential molecular markers for early detection and intervention.
Main Methods:
- Literature review of genetic changes in astrocytoma development.
- Analysis of molecular alterations across different grades of astrocytoma.
Main Results:
- Distinct molecular differences exist between primary and secondary GBM.
- Early genetic changes are critical in the multistep process of malignant transformation.
- Identifying these initial genetic events is key for understanding tumor progression.
Conclusions:
- Focusing on early genetic changes in low-grade astrocytomas offers therapeutic potential.
- Further research into these early alterations could improve patient outcomes.
- Molecular insights may differentiate GBM origins, aiding targeted treatment strategies.
